Academic History
Edward Cliff, MPH, MBBS, is a Research Affiliate on the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital, Boston, MA. He is also an Honorary Clinical Lecturer at the University of Melbourne, Melbourne, Australia and a Hematology Registrar at the Peter MacCallum Cancer Centre, Melbourne, Australia.
Dr Cliff studied a Bachelor of Medical Science (Hons) at the University of Oxford, Oxford, UK, followed by a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health, Boston, MS.
Speaking on improving CAR-T therapies and the treatment of DLBCL
Dr Cliff speaks on the improvement of CAR-T therapies through the analysis of cost-effectiveness and accessibility. He also discusses treatment for patients with diffuse large B-cell lymphoma (DLBCL), as investigated in the POLARIX trial (NCT03274492), and subgroup classification of DLBCL.
